Two polygenic mouse models of major depressive disorders identify TMEM161B as a potential biomarker of disease in humans.
El Yacoubi M, Altersitz C, Latapie V, Rizkallah E, Arthaud S, Bougarel L, Pereira M, Wierinckx A, El-Hage W, Belzeaux R, Turecki G, Svenningsson P, Martin B, Lachuer J, Vaugeois JM, Jamain S.
El Yacoubi M, et al. Among authors: vaugeois jm.
Neuropsychopharmacology. 2024 Feb 7. doi: 10.1038/s41386-024-01811-8. Online ahead of print.
Neuropsychopharmacology. 2024.
PMID: 38326457